These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

608 related items for PubMed ID: 10206300

  • 1. Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas.
    Forsyth PA, Wong H, Laing TD, Rewcastle NB, Morris DG, Muzik H, Leco KJ, Johnston RN, Brasher PM, Sutherland G, Edwards DR.
    Br J Cancer; 1999 Apr; 79(11-12):1828-35. PubMed ID: 10206300
    [Abstract] [Full Text] [Related]

  • 2. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
    Yamamoto M, Mohanam S, Sawaya R, Fuller GN, Seiki M, Sato H, Gokaslan ZL, Liotta LA, Nicolson GL, Rao JS.
    Cancer Res; 1996 Jan 15; 56(2):384-92. PubMed ID: 8542596
    [Abstract] [Full Text] [Related]

  • 3. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors.
    Nakada M, Nakamura H, Ikeda E, Fujimoto N, Yamashita J, Sato H, Seiki M, Okada Y.
    Am J Pathol; 1999 Feb 15; 154(2):417-28. PubMed ID: 10027400
    [Abstract] [Full Text] [Related]

  • 4. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas.
    Nakamura H, Ueno H, Yamashita K, Shimada T, Yamamoto E, Noguchi M, Fujimoto N, Sato H, Seiki M, Okada Y.
    Cancer Res; 1999 Jan 15; 59(2):467-73. PubMed ID: 9927064
    [Abstract] [Full Text] [Related]

  • 5. Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors.
    Lampert K, Machein U, Machein MR, Conca W, Peter HH, Volk B.
    Am J Pathol; 1998 Aug 15; 153(2):429-37. PubMed ID: 9708803
    [Abstract] [Full Text] [Related]

  • 6. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB, Westphal JR, Zendman AJ, Becker JC, Ruiter DJ, van Muijen GN.
    J Pathol; 2000 Jul 15; 191(3):245-56. PubMed ID: 10878545
    [Abstract] [Full Text] [Related]

  • 7. Differential expression of MT1-MMP (MMP-14) and collagenase III (MMP-13) genes in normal and wounded rat corneas.
    Ye HQ, Maeda M, Yu FS, Azar DT.
    Invest Ophthalmol Vis Sci; 2000 Sep 15; 41(10):2894-9. PubMed ID: 10967042
    [Abstract] [Full Text] [Related]

  • 8. Differential expression and localization of TIMP-1 and TIMP-4 in human gliomas.
    Groft LL, Muzik H, Rewcastle NB, Johnston RN, Knäuper V, Lafleur MA, Forsyth PA, Edwards DR.
    Br J Cancer; 2001 Jul 06; 85(1):55-63. PubMed ID: 11437402
    [Abstract] [Full Text] [Related]

  • 9. Expression of gelatinase A and its activator MT1-MMP in the inflammatory periprosthetic response to polyethylene.
    Nawrocki B, Polette M, Burlet H, Birembaut P, Adnet JJ.
    J Bone Miner Res; 1999 Feb 06; 14(2):288-94. PubMed ID: 9933484
    [Abstract] [Full Text] [Related]

  • 10. The value and correlation between PRL-3 expression and matrix metalloproteinase activity and expression in human gliomas.
    Kong L, Li Q, Wang L, Liu Z, Sun T.
    Neuropathology; 2007 Dec 06; 27(6):516-21. PubMed ID: 18021371
    [Abstract] [Full Text] [Related]

  • 11. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human urothelial carcinomas.
    Kitagawa Y, Kunimi K, Ito H, Sato H, Uchibayashi T, Okada Y, Seiki M, Namiki M.
    J Urol; 1998 Oct 06; 160(4):1540-5. PubMed ID: 9751409
    [Abstract] [Full Text] [Related]

  • 12. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
    Ries C, Loher F, Zang C, Ismair MG, Petrides PE.
    Clin Cancer Res; 1999 May 06; 5(5):1115-24. PubMed ID: 10353746
    [Abstract] [Full Text] [Related]

  • 13. Gelatinase expression in ocular surface disorders.
    Sakimoto T, Shoji J, Kanno H, Sawa M.
    Jpn J Ophthalmol; 2004 May 06; 48(1):17-22. PubMed ID: 14767645
    [Abstract] [Full Text] [Related]

  • 14. [Increased expression of gelatinases A and B, matrilysin and TIMP-1 genes in human malignant gliomas ].
    Nakano A, Tani E, Yamamoto Y, Furuyama J, Miyazaki K.
    Nihon Rinsho; 1995 Jul 06; 53(7):1816-21. PubMed ID: 7630025
    [Abstract] [Full Text] [Related]

  • 15. Expression and localization of matrix metalloproteinases (MT1-MMP, MMP-2) and tissue inhibitor of metalloproteinase-2 (TIMP-2) during synepitheliochorial placentation of goats (Capra hircus).
    Uekita T, Yamanouchi K, Sato H, Tojo H, Seiki M, Tachi C.
    Placenta; 2004 Nov 06; 25(10):810-9. PubMed ID: 15451196
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Expression of matrix metalloproteinases during murine chorioallantoic placenta maturation.
    Teesalu T, Masson R, Basset P, Blasi F, Talarico D.
    Dev Dyn; 1999 Mar 06; 214(3):248-58. PubMed ID: 10090151
    [Abstract] [Full Text] [Related]

  • 19. Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas.
    Kossakowska AE, Urbanski SJ, Watson A, Hayden LJ, Edwards DR.
    Oncol Res; 1993 Mar 06; 5(1):19-28. PubMed ID: 8369572
    [Abstract] [Full Text] [Related]

  • 20. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K, Shigemasa K, Nagai N, Ohama K.
    Int J Oncol; 2000 Oct 06; 17(4):673-81. PubMed ID: 10995877
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.